Call for combination therapy in high-risk cardiovascular patients
This content has been produced by ADG in association with Amgen.
There is still a large gap between guideline-recommended LDL-C target levels in high-risk patients and what is achieved in real world practice, warn leading cardiologists in a new viewpoint article.1